Skip to main content

Table 3 Practice guideline 1: resected NSCLC stage II and IIIA patients

From: A mixed methods approach to understand variation in lung cancer practice and the role of guidelines

Item

Rating percent A

Mean

Sd

Mode

Disagree

Neutral

Agree

Assessment of the Recommendations

a. Aware of the recommendations

4.9

2.4

92.7

6.3

1.2

7.0

b. Agree with the recommendations

5.0

0

95.0

6.3

1.1

7.0

c. Recommendations are unambiguous

7.5

7.5

85.0

5.9

1.5

7.0

d. Recommendations are supported by the evidence

2.5

0

97.5

6.4

0.9

7.0

e. Recommendations are current

7.7

2.6

89.7

6.0

1.3

6.0

f. Recommendations are easy to apply in their clinical context

2.6

10.3

87.2

6.2

1.3

7.0

g. Recommendations are too rigid for the patients they are intended

68.4

10.5

21.1

2.9

1.8

2.0

h. Recommendations do not align with how they typically manage these patients

80.0

5.0

15.0

2.4

1.8

1.0a

i. Recommendations apply to the patients they target

7.9

0

92.1

6.0

1.3

6.0

j. Recommendations are biased

82.9

9.8

7.3

2.0

1.6

1.0

k. Support for the recommendations

5.0

2.5

92.5

6.3

1.1

7.0

l. Clinical practice of respondent aligns with the recommendations

5.0

5.0

90.0

6.2

1.1

7.0

Assessment of the Evidentiary Base

a. It is complete

7.7

5.1

87.2

6.0

1.2

7.0

b. It is convincing

2.6

5.1

92.3

6.1

1.0

7.0

c. It is informative

7.5

0

92.5

6.1

1.2

7.0

d. It is relevant to typical patients

12.5

2.5

85.0

6.0

1.6

7.0

e. It is strong

5.3

2.6

92.1

5.9

1.2

6.0

f. It is current

10.5

2.6

86.8

5.8

1.5

6.0a

  1. NSCLC, non-small cell lung cancer.
  2. ADisagree (ratings 1 to 3 on 7-point scale); Neutral (rating 4 on 7-point scale); Agree (rating 5 to 7 on 7-point scale).
  3. aMultiple mode exists. The smallest value is shown.